Abstract:Biofilm development by bacteria is a serious issue in many different sectors, including the food, pharmaceutical, water, petroleum, and others. Because biofilms are difficult to remove due to their capacity to survive in bad environments, attempts were undertaken throughout this work to biologically manufacture gold nanoparticles with possible antibiofilm capabilities. During this study, 19 morphologically distinct fungal cultures were isolated from soil samples and used to synthesize gold nanoparticles. Among 19 fungi, 7 were producing gold nanoparticles and these particles were subjected to antimicrobial activity. Among 7 gold nanoparticles, nanoparticles synthesized from S2-10 isolate of fungi exhibited high antimicrobial activity toward biofilm-forming drug-resistant bacteria including Klebsiella pneumoniae (14.6 ± 0.57 mm), Aeromonas hydrophila (13.3 ± 0.57 mm) and Escherichia coli (10.0 ± 1.0 mm), and was used for further studies. The chosen nanoparticle also shown strong anti-biofilm action against test microorganisms on a variety of material substrates, including plastic, metal, and glass. These nanoparticles also exhibited inhibition of microcolony/initial biofilm, mature and preformed biofilm formed by Klebsiella pneumoniae (53.42 ± 4.45%, 62.14 ± 7.45%, and 24.12 ± 9.87%, respectively), Aeromonas hydrophila (43.89 ± 0.95%, 59.79 ± 1.19%, and 54.85 ± 6.50%, respectively) and Escherichia coli (45.28 ± 6.88%, 45.17 ± 3.94%, and 32.39 ± 4.16%, respectively). The physicochemical characterization of potential nanoparticles was conducted using UV-visible Spectrophotometer, X-ray diffractionSpectroscopy (XRD), Energy Dispersive X-ray (EDX) spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR), and Scanning Electron Microscopy (SEM). These physicochemical analyses confirmed the formation of gold nanoparticles which were found to be spherical in shape with the size between 30 and 40 nm. Furthermore, the potential fungal isolate S2-10 was characterized as Aspergillus niger isolate CJ14 with the help of morphological and molecular techniques and deposited at National Center for Biotechnology Information (NCBI) (Accession number MN519438.1). Hence, it can be concluded that the gold nanoparticles produced using A. niger isolate CJ14 contain significant antibiofilm properties and can be used for developing antibiofilm products for future applications.

Inhibition of Biofilm and Virulence Properties of Pathogenic Bacteria by Silver and Gold Nanoparticles Synthesized from Lactiplantibacillus sp. Strain C1

Silver nanoparticles synthesized by probiotic bacteria and antibacterial role in resistant bacteria

Biosynthesis of silver nanoparticle using Bacillus licheniformis culture-supernatant for combating pathogenic biofilms

Bioprospecting a Native Silver-Resistant Bacillus Safensis Strain for Green Synthesis and Subsequent Antibacterial and Anticancer Activities of Silver Nanoparticles.

Lethal Mechanisms of Nostoc-Synthesized Silver Nanoparticles Against Different Pathogenic Bacteria

Antibiofilm and antivirulence activities of laminarin-gold nanoparticles in standard and host-mimicking media

Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles

Inhibition of Mixed Biofilms of Candida albicans and Staphylococcus aureus by β-Caryophyllene-Gold Nanoparticles

Biosynthesis of gold nanoparticles and inhibition of various stages of bacterial biofilms formed by drug-resistant Aeromonas hydrophila, Escherichia coli, and Klebsiella pneumoniae

Green synthesis of silver, starch, and zinc oxide mediated nanoparticles with probiotics and plant extracts, their characterization and anti-bacterial activity

Biofilm inhibition of Staphylococcus aureus by silver nanoparticles derived from Hellenia speciosa rhizome extract

Cell-free supernatant-assisted biogenic silver nanoparticles enhance the antibacterial efficacy of communicating bacterial pathogens

Synergistic Effect of Silver Nanoparticles with Antibiotics for Eradication of Pathogenic Biofilms

Comparative Account of Biogenic Synthesis of Silver Nanoparticles Using Probiotics and Their Antimicrobial Activity Against Challenging Pathogens

Biosynthesized silver nanoparticles for inhibition of antibacterial resistance and biofilm formation of methicillin-resistant coagulase negative Staphylococci

Characteristics of Metallic Nanoparticles (Especially Silver Nanoparticles) as Anti-Biofilm Agents

Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria

Biosynthesis of Silver and Gold Nanoparticles and Their Efficacy Towards Antibacterial, Antibiofilm, Cytotoxicity, and Antioxidant Activities

Antibiofilm efficacy of silver nanoparticles against biofilm of extended spectrum β-lactamase isolates of Escherichia coli and Klebsiella pneumoniae

Enhanced Antibacterial, Anti-biofilm and Antioxidant (ROS) Activities of Biomolecules Engineered Silver Nanoparticles Against Clinically Isolated Gram Positive and Gram Negative Microbial Pathogens

Silver nanoparticles produced from Cedecea sp. exhibit antibiofilm activity and remarkable stability